Amplification of a gene encoding a p53-associated protein in human sarcomas

Cited by (1,001)

Items 901–1,000 of 1,001

1. MDM2 expression in lymphoid cells and reactive and neoplastic lymphoid tissue. Comparative study with p53 expression
   Juan C. Martinez, Marisol S. Mateo, Margarita Sánchez‐Beato, Raquel Villuendas, Juan Luis Orradre, Patrocinio Algara, Lydia Sánchez-Verde, Pedro García, Carmen López, Pedro Martínez et al. · 1995 · The Journal of Pathology
2. Somatostatin Analogs in Oncology: A Look to the Future
   Spencer A. Jenkins, Howard Kynaston, Nick P. Davies, JOHN N. BAXTER, David Nott · 2001 · Chemotherapy
3. Effects of theMDM2promoter SNP285 and SNP309 on Sp1 transcription factor binding and cancer risk
   Stian Knappskog, Per Eystein Lønning · 2011 · Transcription
4. Rhythmic Control of the ARF-MDM2 Pathway by ATF4 Underlies Circadian Accumulation of p53 in Malignant Cells
   Michiko Horiguchi, Satoru Koyanagi, Ahmed M. Hamdan, Keisuke Kakimoto, Naoya Matsunaga, Chikamasa Yamashita, Shigehiro Ohdo · 2013 · Cancer Research
5. Antitumor Activity of Americanin A Isolated from the Seeds of Phytolacca americana by Regulating the ATM/ATR Signaling Pathway and the Skp2–p27 Axis in Human Colon Cancer Cells
   Cholomi Jung, Ji‐Young Hong, Song Yi Bae, Sam Sik Kang, Hyen Joo Park, Sang Kook Lee · 2015 · Journal of Natural Products
6. The Role of MDM2 in Promoting Genome Stability versus Instability
   Mohammad Reza Saadatzadeh, Adily N. Elmi, Pankita H. Pandya, Khadijeh Bijangi‐Vishehsaraei, Jixin Ding, Christopher W. Stamatkin, Aaron Cohen‐Gadol, Karen E. Pollok · 2017 · International Journal of Molecular Sciences
7. Dual function of MDM2 and MDMX toward the tumor suppressors p53 and RB
   Jesús Hernández‐Monge, Adriana Berenice Rousset-Roman, Ixaura Medina‐Medina, Vanesa Olivares‐Illana · 2016 · Genes & Cancer
8. Genetic effects of anorganic bovine bone (Bio-Oss®) on osteoblast-like MG63 cells
   Francesco Carinci, Adriano Piattelli, Marco Degidi, Annalisa Palmieri, Vittoria Perrotti, Luca Scapoli, Marcella Martinelli, Gregorio Laino, Furio Pezzetti · 2005 · Archives of Oral Biology
9. The molecular genetics of pancreatic cancer
   James R. Howe, Kevin C. Conlon · 1997 · Surgical Oncology
10. Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses
    Yuji Kato, Keisuke Nakata, Shigenobu Nagataki, Katsuhisa Omagari, Ryuji FURUKAWA, Yukio KUSUMOTO, Iwao Mori, Heiichiro TAJIMA, Hajime Tanioka, Michitami Yano · 1994 · Cancer
11. Cloning and Characterization of Three Isoforms of OS-9 cDNA and Expression of the OS-9 Gene in Various Human Tumor Cell Lines
    Yayoi Kimura, Mitsuru Nakazawa, M. Yamada · 1998 · The Journal of Biochemistry
12. Deubiquitinases in Neurodegeneration
    Abudu I. Bello, Rituparna Goswami, Shelby L. Brown, Kara M. Costanzo, Taylor Shores, Shefaa K. Allan, Revan Odah, Ryan D. Mohan · 2022 · Cells
13. The SWIB and the MDM2 domains are homologous and share a common fold
    Riccardo Bennett-Lovsey, Sarah E. Hart, Hiroki Shirai, Kenji Mizuguchi · 2002 · Bioinformatics
14. Mutational Analysis of Merkel Cell Carcinoma
    Derek J. Erstad, James C. Cusack · 2014 · Cancers
15. mir-660-p53-mir-486 Network: A New Key Regulatory Pathway in Lung Tumorigenesis
    Cristina Borzi, Linda Calzolari, Giovanni Centonze, Massimo Milione, Gabriella Sozzi, Orazio Fortunato · 2017 · International Journal of Molecular Sciences
16. Overexpression of SERTAD3, a putative oncogene located within the 19q13 amplicon, induces E2F activity and promotes tumor growth
    H Darwish, J M Cho, Martin Loignon, Moulay A. Alaoui‐Jamali · 2007 · Oncogene
17. Induction of MDM2-P2 Transcripts Correlates with Stabilized Wild-Type p53 in Betel- and Tobacco-Related Human Oral Cancer
    Ranju Ralhan, Agarwal Sandhya, Meera Mathur, Bohdan Wasylyk, Nootan Kumar Shukla · 2000 · American Journal Of Pathology
18. Modulation von Protein‐Protein‐Wechselwirkungen mit niedermolekularen organischen Molekülen
    Thorsten Berg · 2003 · Angewandte Chemie
19. Relative quantitation of p53 and MDM2 gene expression in leiomyosarcoma; real-time semi-quantitative reverse transcription-polymerase chain reaction
    Kimitaka Miyajima, Sadafumi Tamiya, Yoshinao Oda, Toshisada Adachi, Tatsuo Konomoto, Hiroyoshi Toyoshiba, Kouji Masuda, Masazumi Tsuneyoshi · 2001 · Cancer Letters
20. P53, apoptosis, and breast cancer
    Diana M. Barnes, Richard S. Camplejohn · 1996 · Journal of Mammary Gland Biology and Neoplasia
21. MDM2/p53 protein expression in the development of colorectal adenocarcinoma
    Ghada Abdel‐Fattah, Boris Yoffe, Bhuvaneswari Krishnan, Vladimir I. Khaoustov, Kamal M.F. Itani · 2000 · Journal of Gastrointestinal Surgery
22. mdm2 gene mediates the expression of mdr1 gene and P-glycoprotein in a human glioblastoma cell line
    S Kondo, Yasuko Kondo, H Hara, Rami Kaakaji, John W. Peterson, Tatsuo Morimura, J Takeuchi, GH Barnett · 1996 · British Journal of Cancer
23. MDM2 interacts with the C-terminus of the catalytic subunit of DNA polymerase varepsilon
    Nikolina Vlatković · 2000 · Nucleic Acids Research
24. Role of p53 Immunohistochemistry in Differentiating Reactive Gliosis From Malignant Astrocytic Lesions
    Hadi Yaziji, Razan Massarani‐Wafai, Meena Gujrati, James G. Kuhns, Alvin W. Martin, Joseph C. Parker · 1996 · The American Journal of Surgical Pathology
25. Nonsyntenic Amplification of MYC with CDK4 and MDM2 in a Malignant Mixed Tumor of Salivary Gland
    Pulivarthi H. Rao, V.V.V.S. Murty, D C Louie, Raju S. K. Chaganti · 1998 · Cancer Genetics and Cytogenetics
26. The role of oncogenes and tumour-suppressor genes in the aetiology of oral, head and neck squamous cell carcinoma.
    John K. Field · 1995 · PubMed Central
27. Lessons from our children
    Sarah S. Donaldson · 1993 · International Journal of Radiation Oncology*Biology*Physics
28. Identification of a CK2 phosphorylation site in mdm2.
    Götz, Claudia, Kartarius, Sabine, Scholtes, Petra, Nastainczyk, Wolfgang, Mathias Montenarh · 1999 · European Journal of Biochemistry
29. Structure of a Stapled Peptide Antagonist Bound to Nutlin-Resistant Mdm2
    Sharon Min Qi Chee, Jantana Wongsantichon, Soo Tng Quah, Robert Charles Robinson, Thomas Leonard Joseph, Chandra Shekhar Verma, David Philip Lane, Christopher John Brown, Farid John Ghadessy · 2014 · PLoS ONE
30. The Pharmacodynamics of the p53-Mdm2 Targeting Drug Nutlin: The Role of Gene-Switching Noise
    Krzysztof Puszyński, Alberto Gandolfi, Alberto d’Onofrio · 2014 · PLoS Computational Biology
31. MDM2promoter SNP285 and SNP309; phylogeny and impact on cancer risk
    Stian Knappskog, Per Eystein Lønning · 2011 · Oncotarget
32. Anticancer activity and potential mechanisms of 1C, a ginseng saponin derivative, on prostate cancer cells
    Xu De Wang, Guang Yue Su, Chen Zhao, Fan Zhi Qu, Peng Wang, Yu Qing Zhao · 2017 · Journal of Ginseng Research
33. Telomerase activity in soft-tissue and bone sarcomas.
    K. Aogi, A Woodman, Virginia Urquidi, D. Charles Mangham, D Tarin, Steve Goodison B · 2000 · PubMed
34. Tissue-specific apoptotic effects of the p53 codon 72 polymorphism in a mouse model
    Gregory Albert Azzam, Amanda K. Frank, Monica Hollstein, Maureen E. Murphy · 2011 · Cell Cycle
35. The Tumor Suppressor Gene TP53: Implications for Cancer Management and Therapy
    Séverine Seemann, Daniela Maurici, Magali Olivier, Claude Caron de Fromentel, Pierre L. Hainaut · 2004 · Critical Reviews in Clinical Laboratory Sciences
36. MDM2 overexpression is rare in ovarian carcinoma irrespective of TP53 mutation status
    William David Foulkes, GWH Stamp, Saliha Afzal, El–Nasir Lalani, CP McFarlane, John Trowsdale, Ian Campbell · 1995 · British Journal of Cancer
37. Correlation of p53 mutations with epidermal growth factor receptor overexpression and absence of mdm2 amplification in human esophageal carcinomas
    Asunción Esteve, Ruggero Montesano, Monica C. Hollstein, Theresa Lehman, Curtis C. Harris, Wei Bo Jiang, I. Bernard Weinstein, Alberto Ruol, Alberto Peracchia · 1993 · Molecular Carcinogenesis
38. The cellular biology of B-cell chronic lymphocytic leukemia
    Jesper Jurlander · 1998 · Critical Reviews in Oncology/Hematology
39. p53 and bcl-2 proteins as prognostic markers in human papillomavirus-associated cervical lesions.
    Kaisa Kurvinen, Kari Juhani Syrjänen, Stina Syrjänen · 1996 · Journal of Clinical Oncology
40. Screening for TP53 mutations in osteosarcomas using constant denaturant gel electrophoresis (CDGE)
    Birgitte Smith‐Sørensen, Mark C. Gebhardt, Peter Kloen, Jim McIntyre, Fernando Aguilar, P Cerutti, Anne‐Lise Børresen‐Dale · 1993 · Human Mutation
41. Targeted covalent inhibitors of MDM2 using electrophile-bearing stapled peptides
    Charoenpattarapreeda, Jiraborrirak, Tan, Yaw Sing, Iegre, Jessica, Walsh, Stephen J., Fowler, Elaine, Eapen, Rohan S., Wu, Yuteng, Sore, Hannah F., Verma, Chandra S., Itzhaki, Laura et al. · 2019 · Chemical Communications
42. MDM2 and MDMX in Cancer and Development
    Jean‐Christophe Marine · 2011 · Current topics in developmental biology/Current Topics in Developmental Biology
43. Differential response between the p53 ubiquitin–protein ligases Pirh2 and MdM2 following DNA damage in human cancer cells
    Wenrui Duan, Li Gao, Xin Wu, Yang Zhang, Gregory A. Otterson, Miguel Angel Villalona-Calero · 2006 · Experimental Cell Research
44. Mdm2: Open questions
    Matthias Dobbelstein, Arnold J. Levine · 2020 · Cancer Science
45. Expression profile of MDM-2 proteins in chronic lymphocytic leukemia and their clinical relevance
    Mohammad A. Haidar, Hamid El-Hajj, Carlos Bueso-Ramos, Taghi Manshouri, Armand B. Glassman, Michael J. Keating, Maher X. Albitar · 1997 · American Journal of Hematology
46. Leptomycin B stabilizes and activates p53 in primary prostatic epithelial cells and induces apoptosis in the LNCaP cell line
    Philip S. Lecane, Taija M. Kiviharju, Robert G. Sellers, Donna M. Peehl · 2003 · The Prostate
47. Chromosomal and genetic imbalances in synovial sarcoma detected by conventional and microarray comparative genomic hybridization
    Yasuko Nakagawa, Kunihiko Numoto, Aki Yoshida, Toshiyuki Kunisada, Hidenori Ohata, Ken Takeda, Daniel Wai, Christopher Poremba, Toshifumi Ozaki · 2006 · Journal of Cancer Research and Clinical Oncology
48. Disruption of estrogen receptor α-p53 interaction in breast tumors: a novel mechanism underlying the anti-tumor effect of radiation therapy
    Wensheng Liu, Margot M. Ip, Matthew B. Podgorsak, Gokul M. Das · 2008 · Breast Cancer Research and Treatment
49. Differentially Expressed Genes in Metastatic Advanced Egyptian Bladder Cancer
    Abdel‐Rahman N. Zekri, Zeinab Korany Hassan, Abeer Ahmed Bahnassy, Hussein Mustafa Khaled, Mahmoud N. El-Rouby, Rasha Haggag, Fouad Abu-Taleb · 2015 · Asian Pacific Journal of Cancer Prevention
50. Solution conformation of an essential region of the p53 transactivation domain
    Maria Victoria Botuyan, Jamil Antonio Momand, Yuan Chen · 1997 · Folding and Design
51. Overexpression of MDM‐2 mRNA and mutation of the p53 tumor suppressor gene in bladder carcinoma cell lines
    Ya‐Tse Cheng, Yuling Li, Jeng Dau Wu, Shih‐Bin Long, Tzong‐Shin Tzai, Ching‐Cherng Tzeng, Ming‐Derg Lai · 1995 · Molecular Carcinogenesis
52. The role of p53 inactivation in human cervical cell carcinoma development
    K Miwa, Shingo Miyamoto, Hisanori Kato, Takashi Imamura, M Nishida, Y Yoshikawa, Y. Nagata, Naomi C. Wake · 1995 · British Journal of Cancer
53. Peripheral nerve sheath tumors histogenesis, classification, and prognosis
    Steven I. Hajdu · 1993 · Cancer
54. Molecular Pathology of Soft Tissue and Bone Tumors
    Andrzej T. Slominski, Jacobo Wortsman, J. Andrew Carlson, Martín C. Mihm, Brian J. Nickoloff, Kenneth D. McClatchey · 1999 · Archives of Pathology & Laboratory Medicine
55. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non‐Hodgkin's lymphoma
    Michael Boe Møller, Ole Nielsen, Niels T. Pedersen · 2002 · Histopathology
56. Relationship of tobacco/alcohol use to p53 expression in patients with lingual squamous cell carcinomas
    J. B. Matthews, Crispian M. Scully, Andreas Jovanovic, Isaäc van der Waal, William Andrew Yeudall, Stephen Stewart Prime · 1993 · European Journal of Cancer Part B Oral Oncology
57. Recent Insights into the Functions of the Retinoblastoma Susceptibility Gene Product
    William G. Kaelin · 1997 · Cancer Investigation
58. Dying to Survive—The p53 Paradox
    Andrea Lees, Tamas Sessler, Simon S. McDade · 2021 · Cancers
59. Design, synthesis and biological evaluation of novel 3,4,5-trisubstituted aminothiophenes as inhibitors of p53–MDM2 interaction. Part 1
    Weisi Wang, Shihao Shangguan, Ni Qiu, Chunqi Hu, Lei Justan Zhang, Yongzhou Hu · 2013 · Bioorganic & Medicinal Chemistry
60. p53: functions, mutations and sarcomas
    Jaclyn Y. Hung, Robin L. Anderson · 1997 · Acta Orthopaedica Scandinavica
61. The p53 tumor suppressor gene
    Thierry Soussi · 1995 · Advances in genome biology
62. Correlation between mutations in p53 gene and protein expression in human lymphomas
    Beatriz Martínez–Delgado, Mercedes Robledo, Eva Arranz, Fernando Infantes, G Echezarreta, B Marcos, C. Sanz, Carmen Rivas, Javier J. Benitez · 1997 · American Journal of Hematology
63. Direct isolation of genes encoded within a homogeneously staining region by chromosome microdissection.
    Yan A. Su, Jeffrey M. Trent, Xin‐Yuan Guan, Paul S. Meltzer · 1994 · Proceedings of the National Academy of Sciences
64. Initial Testing (Stage 1) of MK‐8242—A Novel MDM2 Inhibitor—by the Pediatric Preclinical Testing Program
    Kang, Min H., Reynolds, C. Patrick, Kolb, E. Anders, Gorlick, Richard, Carol, Hernan, Lock, Richard, Keir, Stephen T., Maris, John M., Wu, Jianwrong, Lyalin, Dmitry et al. · 2016 · Pediatric Blood & Cancer
65. Modeling human osteosarcoma in the mouse: From bedside to bench
    Katherine A. Janeway, Carl R. Walkley · 2010 · Bone
66. Negative auto-regulators trap p53 in their web
    Xiang Yu Zhou, Bo Cao, Hua Lu · 2017 · Journal of Molecular Cell Biology
67. GPRC5A deficiency leads to dysregulated MDM2 via activated EGFR signaling for lung tumor development
    Hongyong Song, Beibei Sun, Yueling Liao, Dongliang Xu, Wenzheng Guo, Tong Wang, Bo Jing, Min Hu, Kaimi Li, Feng Yao et al. · 2018 · International Journal of Cancer
68. Targeting Mouse Double Minute 2: Current Concepts in DNA Damage Repair and Therapeutic Approaches in Cancer
    Wen Li, Xinhao Peng, Jinyi Lang, Chuan Shan Xu · 2020 · Frontiers in Pharmacology
69. p53 in Nonneoplastic Central Nervous System Lesions: An Immunohistochemical and Genetic Sequencing Study
    Özlem Yapıcıer, Bernd Walter Scheithauer, Deanne M. Hebrink, Charles David James · 2002 · Neurosurgery
70. Type A botulinum neurotoxin complex proteins differentially modulate host response of neuronal cells
    Lei Wang, Yi Sun, Weiping Yang, Paul Lindo, Bal Ram Singh · 2014 · Toxicon
71. MDM2 promotes rheumatoid arthritis via activation of MAPK and NF-κB
    Lin Zhang, Jing Luo, Hongyan Wen, Tingting Zhang, Xiaoxia Zuo, Xiaofeng Li · 2015 · International Immunopharmacology
72. Immunohistochemical evaluation of erbB-2 and p53 protein expression in benign and atypical human meningiomas
    Bruce S. Chozick, DeborahL. Benzil, Edward G. Stopa, John C. Pezzullo, N. Knuckey, Mel H. Epstein, SydneyD. Finkelstein, Paul W. Finch · 1996 · Journal of Neuro-Oncology
73. High frequency of ki‐ras amplification and p53 gene mutations in adenocarcinomas of the human esophagus
    C Galiana, Jean-Claude Lozano, Brigitte Bancel, Hisayoshi Nakazawa, Hiroshi Yamasaki · 1995 · Molecular Carcinogenesis
74. Mutations within the tumour suppressor gene p53 are not confined to a late event in prostate cancer progression
    Sean R. Downing, Paul Jackson, Pamela Joan Russell · 2001 · Urologic Oncology Seminars and Original Investigations
75. Relevance of cytogenetic and fluorescent in situ hybridization analyses in the clinical assessment of soft tissue sarcoma
    Gabriella Sozzi, Fabiola Minoletti, Monica Rosa Miozzo, Laura Sard, Katia Musso, Alberto Azzarelli, Marco Alessandro Pierotti, Silvana Pilotti · 1997 · Human Pathology
76. Inhibition of p53-Mediated Growth Arrest by Overexpression of Cyclin-Dependent Kinases
    Kathryn M. Latham, Scott W. Eastman, Andrea Wong, Philip W. Hinds · 1996 · Molecular and Cellular Biology
77. Adenovirus-mediated E2F-1 gene transfer inhibits MDM2 expression and efficiently induces apoptosis in MDM2-overexpressing tumor cells.
    Hai Liang Yang, Yan Dong, Mary Jane Elliott, Ta Jen Liu, Cesar A. Atienza, Ariel Stilwell, Kelly M. McMasters · 1999 · PubMed
78. p53 domains: suppression, transformation, and transactivation.
    Michael J. Reed, Yanru Wang, Gregory A. Mayr, Anderson Me, John F. Schwedes, P Tegtmeyer · 1993 · Europe PMC (PubMed Central)
79. Infrequency of MDM2 gene amplification in pediatric solid tumors and lack of association with p53 mutations in adult squamous cell carcinomas.
    Pamela G. Waber, Jiandong Chen, Perry D. Nisen · 1993 · PubMed
80. Widespread Overexpression of Epitope-Tagged Mdm4 Does Not Accelerate Tumor Formation <i>In Vi</i><i>vo</i>
    De Clercq, Sarah, Gembarska, Agnieszka, Denecker, Geertrui, Maetens, Marion, Naessens, Michael, Haigh, Katharina, Haigh, Jody J., Marine, Jean-Christophe · 2010 · Molecular and Cellular Biology
81. Battle Against Cancer: An Everlasting Saga of p53
    Qian Hao, William Cho · 2014 · International Journal of Molecular Sciences
82. Actinomycin D and nutlin-3a synergistically promote phosphorylation of p53 on serine 46 in cancer cell lines of different origin
    Artur Zajkowicz, Agnieszka Gdowicz‐Kłosok, Małgorzata Krześniak, Dorota Ścieglińska, Marek Rusin · 2015 · Cellular Signalling
83. p53 + /mdm2 − Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma in Young Children: An Early Expression of Li-Fraumeni Syndrome
    Larisa V. Debelenko, Antonio R. Pérez‐Atayde, Steven G. DuBois, Holcombe E. Grier, Sung‐Yun Pai, Robert C. Shamberger, Harry P. Kozakewich · 2009 · Pediatric and Developmental Pathology
84. In vivo corrosion, tumor outcome, and microarray gene expression for two types of muscle-implanted tungsten alloys
    Brian Elias Schuster, Laurie E. Roszell, Lawrence E. Murr, D.A. Ramirez, J. D. Demaree, Bradley R. Klotz, Alan B. Rosencrance, William E. Dennis, W. Bao, Edward J. Perkins et al. · 2012 · Toxicology and Applied Pharmacology
85. DNA-damaging Aryl Hydrocarbons Induce Mdm2 Expression via p53-independent Post-transcriptional Mechanisms
    Andrew Y. Hsing, Douglas V. Faller, Cyrus Vaziri · 2000 · Journal of Biological Chemistry
86. Amplification of the mdm2 gene and p53 abnormalities in uterine sarcomas
    Akihiko Seki, Junichi Kodama, Yasunari Miyagi, Shigehito Kamimura, Mitsuo Yoshinouchi, Takafumi Kudo · 1997 · International Journal of Cancer
87. The contribution of the RING finger domain of MDM2 to cell cycle progression
    Manuela Argentini, Nadia Barboule, Bohdan Wasylyk · 2000 · Oncogene
88. p53 gene mutations in soft-tissue sarcomas - correlations with p53 immunohistochemistry and DNA ploidy
    Regine Schneider-Stock, Kathrin Radig, Yoshinao Oda, Walter Mellin, Janusz Ryś, Aleksander Niezabitowski, Albert Roessner · 1997 · Journal of Cancer Research and Clinical Oncology
89. Retraction: Suppression of HMGA2 Protein Synthesis Could Be a Tool for the Therapy of Well Differentiated Liposarcomas Overexpressing HMGA2
    Francesca Pentimalli, Monica Dentice, Monica Fedele, Giovanna Maria Pierantoni, Letizia Cito, Pierlorenzo Pallante, Massimo Mattia Santoro, Giuseppe Viglietto, Paola Dal Cin, Alfredo Fusco · 2018 · Cancer Research · Retracted
90. MDM2 overexpression does not account for stabilization of wild-type p53 protein in non-Hodgkin's lymphomas
    Roberta Maestro, Annunziata Gloghini, Claudio Doglioni, Daniela Gasparotto, Tamara Vukosavljevic, Vallì De Re, Licia Laurino, Antonino Carbone, Mauro Boiocchi · 1995 · Blood
91. Synergistic activity and heterogeneous acquired resistance of combined MDM2 and MEK inhibition in KRAS mutant cancers
    Aaron N. Hata, Steve C. Rowley, Hannah L. Archibald, María Gomez‐Caraballo, F M Siddiqui, Fei Ji, Joonil Jung, Mark E. Light, J S Lee, Laurent Debüssche et al. · 2017 · Oncogene
92. Synthesis and evaluation of novel orally active p53–MDM2 interaction inhibitors
    Masaki Miyazaki, Hiroyuki Naito, Yuuichi Sugimoto, Keisuke Yoshida, Haruko C. Kawato, Tooru Okayama, Hironari Shimizu, Masaya Miyazaki, Mayumi Kitagawa, Takahiko Seki et al. · 2013 · Bioorganic & Medicinal Chemistry
93. Comparative genomic hybridization detects multiple chromosomal amplifications and deletions in undifferentiated embryonal sarcoma of the liver
    Richard D. Sowery, Clara L Jensen, Kevin B Morrison, Douglas E. Horsman, Poul H. B. Sorensen, Eric M. Webber · 2001 · Cancer Genetics and Cytogenetics
94. Soft Tissue Sarcomas and p53 Mutations
    Helge W. Taubert, Axel Meye, Peter Würl · 1998 · Molecular Medicine
95. Stimulation of human DNA polymerase epsilon by MDM2
    Asahara, H. · 2003 · Nucleic Acids Research
96. p53 gene mutations and expression of p53 and mdm2 proteins in invasive breast carcinoma: A comparative analysis with clinico-pathological factors
    Günther, T., Schneider-Stock, R., Ryš, J., Niezabitowski, A., Roessner, A. · 1997 · Journal of Cancer Research and Clinical Oncology
97. Untitled work
    Caraceni · 1998 · 10.1002/(sici)1097-0142(19980801)83:3
98. Untitled work
    Berner · 1996 · 10.1002/(sici)1098-2264(199612)17:4
99. Untitled work
    Wang · 1997 · 10.1002/(sici)1096-9896(199705)182:1
100. Loss of one but not twomdm2 null alleles alters the tumour spectrum inp53 null mice
     McDonnell, Timothy J., Montes de Oca Luna, Roberto, Cho, Song, Amelse, Lisa L., Chavez-Reyes, Arturo, Lozano, Guillermina · 1999 · The Journal of Pathology